Related Experiment Videos
Oestrogen-binding components in human renal cell carcinoma
Abstract:
Specific binding of [3H]oestradiol-17beta by the cytosol fraction of human renal cell carcinoma was studied. The binding reaction displayed marked ligand specificity and high affinity of binding. Unlabelled oestradiol, oestriol and oestrone inhibited the binding of [3H]oestradiol-17beta to the cytosol binding sites, wehereas all other steroids tested turned out to be only weak or insignificant competitors for the oestrogen binding sites. Scatchard analyses suggested the existence of a single class of binding sites. The dissociation constant of the oestradiol-binding complex was found to be 2.51 +/¿.75 x 10(-9) mol/l. The number of binding sites was limited (17.5 +/- 3.8 fmoles per mg of cytosol protein). Sucrose gradient centrifugation revealed these binding components to be macromolecules either displaying a complex sedimentation pattern (peaks at 3.5 S, 4S, 5.7S and, in addition, high molecular weight aggregates) or sedimenting in the 4S region alone. By agar gel electrophoresis it could be demonstrated that the oestradiol-inding components migrated into the receptor region of the gel. Binding of [3H]oestradiol-17beta to these entities was markedly reduced, when the cytosol was heated (60 min at 45 degrees C) prior to the reaction with the labelled hormone. Since the specific binding components exhibit properties of oestradiol receptors in target tissues, a direct effect of oestradiol on human renal cell carcinoma is suggested.
Insights
Human renal cell carcinoma exhibits specific estrogen binding sites, suggesting a direct role for estradiol. These findings indicate potential therapeutic targets for kidney cancer treatment.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Human renal cell carcinoma (RCC) is a significant health concern.
- The role of steroid hormones in RCC development and progression is not fully understood.
Purpose of the Study:
- To investigate the presence and characteristics of specific estradiol binding sites in human RCC cytosol.
- To determine if estradiol has a direct effect on RCC.
Main Methods:
- Radioligand binding assays using [3H]oestradiol-17beta.
- Scatchard analysis to quantify binding sites and affinity.
- Sucrose gradient centrifugation and agar gel electrophoresis to characterize binding components.
- Heat treatment to assess the nature of binding.
Main Results:
- Specific, high-affinity binding of [3H]oestradiol-17beta was observed in human RCC cytosol.
- Scatchard analysis indicated a single class of binding sites with a dissociation constant (Kd) of 2.51 ± 0.75 x 10(-9) mol/L.
- Binding components exhibited properties consistent with estrogen receptors, including sedimentation in the 4S region and migration into the receptor region on agar gel electrophoresis.
- Binding was significantly reduced by heat treatment, suggesting a proteinaceous receptor.
Conclusions:
- Human RCC cytosol contains specific binding components with characteristics of estrogen receptors.
- These findings suggest a potential direct effect of estradiol on human renal cell carcinoma.
- The presence of estrogen receptors in RCC may represent a therapeutic target.